Focus: Mainstay Medical is a medical device company focused on implantable neurostimulation systems for chronic lower back pain, headquartered in Dublin, Ireland. The company operates as a public entity with a focused pipeline centered on the ReActiv8 Implantable Stimulation System.
Profile data last refreshed 6h ago · AI intelligence enriched 2mo ago
Best suited for commercial, regulatory, or reimbursement professionals seeking growth in a focused device company; limited appeal for research scientists.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Lead product for multifidus nerve stimulation in chronic lower back pain, currently in market or late-stage development with Phase 4 data collection underway.
Help build intelligence for Mainstay Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Mainstay Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Correction to: ISSLS Prize in Basic Science 2025: Structural changes of muscle spindles in the multifidus muscle after intervertebral disk injury are resolved by targeted activation of the muscle.
ISSLS Prize in Basic Science 2025: Structural changes of muscle spindles in the multifidus muscle after intervertebral disk injury are resolved by targeted activation of the muscle.
Showing 5 of 10 publications